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Abstract
Purpose of the Review Conditions typically prevalent in adults such as hypertension, kidney stones, osteoporosis, and chronic
kidney disease are increasing among adolescents and young adults (AYA). The purpose of this review is to describe the
association of these conditions to a high salt diet among pediatric patients.
Recent Findings We present animal, human, and 23Na MRI evidence associated with the negative impact of high dietary salt
in children. Special focus is placed on novel 23Na MRI imaging which reveals the important concept of a third compartment
for sodium storage in soft tissue. Finally, we make recommendations on who should not be on a low salt diet.
Summary A high salt intake predisposes children and AYA to considerable morbidity. We exhort the reader to engage in
advocacy efforts to curve the incidence and prevalence of high salt-related life-limiting conditions.
Keywords Sodium MRI · Urinary stone disease · Hypertension · Hypertension in offspring · Chronic kidney disease ·
Cardiovascular morbidity
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Introduction
Life expectancy has been declining steadily in North America over the past 5 years [1], even before the COVID-19
pandemic, owing to poor diet and lifestyle choices. Of the
modifiable factors, limiting dietary salt is important. Prehistoric man was characteristically exposed to very low levels
of dietary sodium—typically with 20 times higher potassium
than sodium in their urine (sodium/potassium ratio 0.02);
life expectancy reached 70 years and modern day noncommunicable diseases such as heart attacks and strokes
were almost absent [2]. In stark contrast, we can find urinary sodium/potassium ratios of 10 (healthy < 2.4) in youth
with kidney stones [3]. Diseases that used to be described
in adults such as hypertension, kidney stones, type II diabetes, metabolic syndrome, and even cardiovascular disease
are increasing among adolescents and young adults (AYA)
[4–7]—all potentially linked to increased sodium exposure.
Socioeconomic status is inversely correlated with salt
intake as low-cost foods contain great amounts of salt in
general [8]. In fact, up to 75% of the salt intake is due to processed food [9]. The authors of this review are particularly
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concerned about the impact of high dietary salt in children
of families with low socioeconomical means, who cannot
afford the cost of some low sodium foods. The gap between
rich and poor is increasing in developed countries, and in
view of the detrimental impact of high salt diet in childhood on longevity and all-cause mortality, we need a call
to action. The food industry uses the cheapest preservatives
to increase the shelf life of products and profits. Therefore,
access to low salt food becomes a matter of social injustice
and legislature changes are required to limit salt in processed
food, similar to what has been done in Finland, Argentina,
and South Africa [10]. The purpose of this review is to
summarize the recent literature on salt intake and morbidity in children and AYA, since comprehensive legislation to
lower salt in processed food is an easily modifiable factor
to improve longevity and reduce salt related morbidity and
mortality.

The Impact of a High Salt Diet the Unborn
It has long been known that maternal diet during pregnancy
can have a profound impact on the offspring. Too much salt
is already a problem since salt worsens the edema of the
face, hands, legs, ankles, and feet commonly experienced by
the mother during pregnancy. Moreover, high maternal salt
intake affects the fetal renal renin angiotensin aldosterone
system (RAAS). According to the Dietary Guidelines for
Americans established by the Department of Agriculture and
the Department of Health and Human Services, the recommendation is up to about a teaspoon of salt a day—that is,
6 g of salt, or approximately 2300 mg of sodium. However,
most people living in North America consume more than
3500 mg of sodium per day, including pregnant women [11,
12].
The developmental origins of health and disease theory
indicates that many adult-onset diseases originate in the
earliest stages of life. The developing kidney is particularly
vulnerable to adverse in utero conditions, leading to morphological and functional changes and potentially suboptimal nephron endowment. Malnutrition is the common factor related to hypertension and kidney disease; however, a
variety of nutritional insults can cause renal programming
including high sucrose and fructose consumption, protein
and calorie restriction, and high fat diet [13]. High salt diet
during pregnancy needs to be added to this list, at least suggested by data derived from experimental study of female
Wistar rats [13, 14]. Oxidative stress, an imbalance between
reactive oxygen/nitrogen species and antioxidant systems,
plays a pathogenic role in the developmental programming
of kidney disease [15]. There is increasing evidence that
activation of the RAAS increases oxidative stress. This is
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important since there is a finite nephron endowment that
develops until 36 weeks of gestational age [16].
Another possible explanation is the induction of expression of renal angiotensin II due to a high salt diet [14]. Animal studies suggest that intra-uterine exposure to high salt
is associated with activation of the local RAAS (which persisted after birth), a risk factor for the development of kidney
or cardiovascular diseases. When pregnant ewes were fed
a high salt diet for 2 months during mid to late gestation,
their offspring were noted to have high urinary sodium with
lower urine volume compared to those exposed to a low
salt diet [17]. Those with a high salt diet had persistently
elevated serum sodium up until 15 and 90 days of age. Furthermore, ewes with a high salt diet had a greater mRNA
expression relating to angiotensin, angiotensin 1 (AT1),
angiotensin 2 ( AT2), angiotensin converting enzyme (ACE)
levels, and ACE:ACE2 ratio [17]. In another set of experiments, vascular dysfunction has been demonstrated in adult
offspring of AT1 receptor antibody positive pregnant rats
exposed to a high salt diet in utero [18]. Prenatal exposure
to AT2 has been shown to cause reduced nephron endowment and kidney impairment in male rat offspring [19]. The
results from the latter study suggest that prenatally increased
AT2 promoted infiltration of immune cells in the kidney and
subsequent oxidative stress, inducing damage of the renal
glomerular and tubular system, entailing negative consequences on the cardiovascular system [19].
Taken together, current evidence strongly suggests that
the RAAS plays a significant role on renal programming. As
shown here, animal data suggest that a high salt diet during
pregnancy contributes to this and may be responsible for
hypertension and CKD later in life. This concept warrants
further research.

Hypertension and Salt
Determination of total body sodium content in vivo has
been challenging till the recent development of sodium-23
magnetic resonance imaging (23Na MRI), which allows the
non-invasive quantification of tissue sodium content [20].
We have applied a relatively standard approach to sodium
imaging to directly study tissue accumulation in children.
Briefly, a multinuclear-capable 3.0-Tesla MRI scanner (Discovery MR750 3.0 T, General Electric Healthcare, Milwaukee, WI, USA) is used to acquire 23Na spin-density images
of the lower leg, for which subjects were positioned in the
magnet bore in the supine position, with the thickest part of
their right or left calf muscle at the center of a custom-made
23
Na birdcage radiofrequency coil. Calibration vials with 10,
20, 30, and 40 mmol/L of saline are placed in the RF coil
over the subjects’ shins. A single-slice 23Na MRI image is
obtained with a radial k-space acquisition pulse sequence
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known as “Density-Adapted 2D Projection Reconstruction,” with the following parameters: slice-selective radiofrequency pulse; flip angle 90°; repetition time/echo time:
100/1.2 ms; total acquisition time: 30 min; number of signals
averages, 100; slice thickness, 30 mm and isotropic field of
view/resolution, 18/0.3 c m2. During the same imaging session, additional axial 1H MR images were acquired using a
standard “Spoiled Gradient-Recalled Echo” pulse sequence
to identify and delineate the relevant anatomical structures.
Healthy children (n = 17) had a median skin sodium concentration of 13.4 (3.3 interquartile range [IQR]), whereas
19 healthy adults had a median skin sodium concentration
of 18.7 (6.2 IQR). Similarly, muscleSoleus sodium concentrations were 18.6(1.6 IQR) in children and 22.2 (4.3 IQR) in
adults (unpublished results). Sodium concentrations correlated with age. CKD and dialysis patients had much higher
sodium concentrations compared to normal controls (in adult
patients), and skin sodium concentration was higher in a
small cohort (10 subjects) of children with CKD c.f. with
age matched controls.
While there is ample evidence for sodium accumulation going hand in hand with fluid retention to maintain the
environmental effective osmotic pressure gradient (tonicity)
[21, 22], experimental evidence has also shown that the skin
is a reservoir for water-free sodium in mammals including
humans [23, 24]. However, similar studies in children and
adolescents remain scant. Sodium accumulation has been
experimentally associated with endothelial dysfunction and
vascular stiffening [25, 26]. Tissue sodium has been shown
to be mobilized by loop diuretic therapy [27], hemodialysis
[28], and the novel sodium glucose cotransporter 2 (SGLT2)
inhibitors [29•]. SGLT2 inhibitors are a class of drug widely
used in the management of type 2 diabetes mellitus that work
by inhibiting the reabsorption of glucose in the proximal
convoluted tubule [30]. This class of medications inhibits
the coupled reabsorption of sodium and glucose, thereby
increasing urinary sodium and glucose wasting. The natriuretic effects coupled with tissue sodium depletion may be
one of the main reasons why these medications have such a
profound effect on cardiovascular complications [31].
However, in children and adolescents, the importance of a
low sodium diet is poorly elucidated. During the first 3 days
of life, preterm infants have a lower concentration ability
than full-term babies. Tubular immaturity is associated with
greater natriuresis until about 3 weeks of life [32]. While
a positive sodium balance promotes growth in childhood,
studies that correlate a high salt diet and hypertension during
childhood are difficult to conduct. These studies rely on food
diaries, 24-h urinary Na, or spot urinary Na/creatinine ratio,
making absolute Na intake unreliable. Aparicio et al. showed
in a study of 205 school children that the sodium intake of
hypertensive children was higher than that of normotensive
children [33]. Owing to obesity and high salt intake, high
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blood pressure is increasingly becoming prevalent among
children and youth. A meta-analysis of 10 controlled trials
[34] assessed the effect of reducing dietary salt in hypertension (n = 966 patients, ages 8–16 years); and a reduction of
salt by 42%, reduced systolic, and diastolic blood pressure
[34]. In the same publication, three trials of infants and children ages 8 weeks to 6 months who had a 56% reduction in
dietary salt also had a reduction in systolic blood pressure
[34].
Roth and coworkers used 23Na MRI in 32 obese adolescents aged 13–17 years of which 11 had arterial hypertension. Median skeletal muscle Na + content in hypertensive
obese (11.95 mmol/L [interquartile range 11.62–13.66])
was significantly lower than in normotensive obese
(13.63 mmol/L [12.97–17.64]; p = 0.043) or controls
(15.37 mmol/L [14.12–16.08]; p = 0.012). No significant
differences were found between normotensive obese individuals and control subjects [35]. Unfortunately, the question
whether tissue sodium concentration is associated with the
development of hypertension in children and adolescents
is understudied. However, mechanistic computer modeling
would suggest that large vessel stiffness owing to sodium
retention resulting in peripheral resistance could be the
prime source of arterial hypertension even in a newborn with
acute kidney injury [36].

Urinary Stone Disease and Salt
Traditionally, urinary stone disease (USD) has been a disease of older males. In children and AYA, USD was rare
and mostly related to rare genetic conditions such as renal
tubular acidosis, cystinuria, or hyperoxaluria [3]. However,
we are witnessing an unprecedented increase of USD in
AYA, especially among females [4, 37–40]. Based on the
data in one of our own centers, the number of patients with
USD quadrupled among 10 to 17-year-olds studied from
2015 to 2019, tripling among young adults (Fig. 1). Most
of these patients did not have any inherited causes for USD
identified. Hypercalciuria and insufficient citrate with a urinary calcium/citrate ratio > 1 are most often found in these
patients [41].
USD is a critical public health concern as it is associated
with osteoporosis, the development of CKD, and shortened
life-expectancy [42, 43]. A large proportion of USD patients
already developed decreased bone mineral density [44, 45].
Interestingly, this was more prevalent in adolescent males
[46], even though females tend to have lower bone mineral
density z-scores than males. A major reason for USD is the
steady increase in dietary sodium intake in Western countries (typically > 3500 mg/day, whereas the World Health
Organization (WHO) recommends < 2000 mg/day) [11, 12,
47, 48]. The sodium intake in the USA for children aged
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Fig. 1  Unique new patients at the hospitals of the University of North
Carolina at Chapel Hill from 2015–2019

6–11 years of age increased from 200 mg/day in the 1970s
to 3000 mg/day in the 2000s [49]. There is a direct relationship between urinary sodium excretion and urinary calcium
wasting [50]. This makes limiting the salt intake the easiest
step to reduce the lithogenic risk [51].
Unfortunately, socioeconomic status is inversely correlated with salt intake, as low-cost foods are highly salted in
general [8], with up to 75% of the salt intake derived from
ingestion of processed food [9]. On this basis, the recognized correlation between socioeconomic status and USD
[52] is unsurprising. The American Urological Association
recommends limitation of sodium intake [53], but this may
be impossible for low-income families who have to rely on
inexpensive, processed food.

Osteoporosis and Salt
Osteoporosis is a major public health problem, affecting 16%
of men and 29.9% of women older than 50 years of age in
the USA [54]. A high sodium, high protein, and high salt
diet is one of the most important factors driving osteoporotic
disease progression [55]. While the etiology of osteoporosis is multifactorial, high salt intake is a major risk factor
for the development of osteoporosis [56]. The relationship
between osteoporosis and a high salt diet is the same as for
USD; high salt intake requires the kidneys to excrete more
salt, which inhibits the calcium reabsorption in the distal
tubule [57]. Since the calcium homeostasis requires that
serum calcium remains very tightly controlled, salt-induced
calcium wasting leads to the need of mobilization of bonederived calcium aggravated by the fact that many children
and adolescents in North America are vitamin D deficient
[48, 58]. Epidemiological studies suggest that osteoporosis
is affecting younger and younger people [59]. Rendina et al.
highlight the linkage between USD and osteoporosis and

propose to call the combination of both a new syndrome
[59]. Furthermore, children and youth with neuromuscular
disorders, chronic diseases, and low motor competence are
particularly at risk for the future development of osteoporosis [60].
Adolescents accrue bone mineral density only until early
adulthood [61]; there is evidence to suggest that peak bone
mass and later fracture risk are influenced by the pattern of
growth in childhood and by nutritional exposures in utero,
in infancy, and during childhood and adolescence.
Unfortunately, the typical developed country diets of children and youth consist of high protein intake (i.e., large acid
load), high salt intake (i.e. calcium wasting), and low fruit
and vegetable intake—which serve as an important source
of buffers. Large population-based studies of bone mineral
density in adolescents are lacking but based on the findings
in USD patients and the continuously rising salt intake in our
population, we may face a future increase of osteoporosis
constituting a further major public health problem.

Sodium‑23 Magnetic Resonance Imaging
and Chronic Kidney Disease
The relationship between salt intake, blood pressure, cardiovascular, and kidney diseases has been the subject of
a considerable volume of research [62]. Traditional clinical estimates of sodium status include serum sodium and
24-h urine sodium excretion but are poor estimates of total
body sodium. Recently, 23Na MRI became available as a
non-invasive tool to estimate sodium accumulation in soft
tissues such as skin and muscles in the extremities [63, 64].
Importantly, this imaging technique does not distinguish
water-bound from water-free sodium, and increased tissue
sodium concentrations are mainly a function of extracellular
volume expansion [65]. Skin and muscle sodium concentrations increase with age likely due to a reduction of cellular
mass in favor of interstitial expansion [22, 63]. Larger skin
sodium concentrations have also been observed in male sex
compared with females and may be relevant in the pathophysiology of essential hypertension in humans [63].
Preliminary observations from our group point out that
children may have the lowest tissue sodium concentration
[66•], as opposed to adult dialysis patients where tissue
sodium concentrations are largest [67, 68]. Though intuitively increased dietary sodium intake should be associated with increased tissue sodium levels, clinical evidence
in this respect is scarce; Bracconier et al. have shown that
in healthy individuals, higher salt intake is associated with
higher sodium concentrations in muscle tissue and sweat
[69•]. Elevated sodium content has been demonstrated in
several pathological states in adults, suggesting a potential
role of sodium accumulation as a mediator of outcomes:
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primary hyperaldosteronism [20], type 2 diabetes mellitus
[70], acute heart failure [27], CKD, and kidney failure [71].
In our own current work, in the pediatric population, we
observed that the sodium status differs between kidney disease etiologies—likely reflecting variable kidney sodium
handling for different disease states. Glomerular diseases
causing nephrotic syndrome are associated with primary
sodium reabsorption and increased total body sodium [72]
and lead to larger sodium accumulation, whereas some tubular diseases such as idiopathic Fanconi syndrome are associated with kidney sodium wasting and result in substantial
tissue sodium depletion compared with healthy age and sexmatched controls [66•]. As a proof-of-concept, we represent
23
Na MRI results of a 14-year-old hemodialysis patient (primary etiology of focal and segmental glomerulosclerosis)
showing dramatic skin and muscle sodium accumulation,
as compared to a healthy 14-year-old (Fig. 2).

The Problem with the Food Industry
A fundamental problem remains in the refusal of the food
industry to voluntarily reduce the salt in the food. Salt is an
effective and inexpensive food preservative, thereby increasing product shelf life, simplifying logistics, and maximizing
profits. Despite the fact that the WHO declared a war on salt

Fig. 2  23Na MRI of the leg in a 14-year-old healthy female (A) and
a 14-year-old female patient with end-stage CKD (B). Images show
a substantially increased whole leg sodium concentration 
([Na+])
(A 15.9 vs B 36.2 mmol/L, Z-score + 12.2) skin [Na+] (A 10.5 vs
B 30.4 mmol/L, Z-score + 7.0), and triceps surae muscle [Na+] (A
19.5 vs B 38.2 mmol/L, Z-score + 11.0). Na+ measurement was pos-
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and made a reduction of sodium intake below 2000 mg/day
a high priority (endorsed by all WHO members), only nine
countries have any legislation about how much salt can be
added to the food through industry and restaurants. Of these,
six only pertain to bread which accounts for 26% of the daily
salt intake mainly as result of how much of this relatively
low salt-containing foodstuff is typically consumed. Only
Finland, South Africa, and Argentina have comprehensive
salt laws [10].

Who Should Not Be on a Low Salt Diet?
It is very clear that some children and AYA with tubular
diseases are salt wasters. For instance, there is no place for
sodium restriction in patients with Fanconi syndrome [66•].
Another example are patients with KCNJ16 mutations resulting in a novel tubulopathy with salt wasting [73]. Renal salt
wasting may result from cystinosis, Dent disease, disorders
of paracellular claudin-10b, and Kir4.1 potassium-channel
deficiency [74]. We recently described profound salt wasting
in a patient with compound heterozygous Bartter syndrome
(KCNJ1 gene, a frameshift deletion, p.Glu334Glyfs*35, and
a missense variant, p. Pro110Leu) [75]. Obviously, these
patients must not be on a low salt diet. 23Na MRI studies in
these patients remain scant. It has been shown repeatedly

sible by linear trend analysis as detailed in [71], using three to four
calibration vials containing increasing concentrations of NaCl solution (from left to right in A 40, 20, 10 mmol/L, and in B 40, 30, 20,
10 mmol/L). Tissue [Na+] is displayed as heat map, with greater signal intensity proportional to tissue [Na+]
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that serum sodium and urinary 24-h sodium excretion are
not sufficient to diagnose sodium wasting or sodium retention. 23Na MRI forms a potent, non-invasive tool to determine tissue sodium content and may help to guide dietary
and medication interventions for hypertension, heart failure,
osteoporosis, USD, and other non-communicable disorders.

Conclusions
This review highlights the relationship between high salt
intake and chronic life-limiting conditions such as hypertension, USD, osteoporosis, and CKD in children and AYA as
well as the importance of sodium accumulation in the body,
measured by 23Na MRI of muscle and skin. The high salt
diet in Western societies may be the easiest modifiable factor
to curb the growing prevalence of these non-communicable
diseases. Obviously, salt wasters must be identified and supplemented accordingly. We exhort the reader to engage in
advocacy efforts to curb the incidence and reduce the prevalence of high salt-related life-limiting conditions.
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